Business Description
Covetrus Inc
NAICS : 423460
SIC : 5122
Compare
Compare
Traded in other countries / regions
2NJ.Germany
•
CVET.USA
Description
Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe and the Asia Pacific (APAC) and Emerging Markets. The company's services include supply chain services, software solutions, and prescription management.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.7 | |||||
| Debt-to-EBITDA | 5.3 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.09 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.6 | |||||
| 3-Year EBITDA Growth Rate | -11.7 | |||||
| 3-Year FCF Growth Rate | -36.9 | |||||
| 3-Year Book Growth Rate | -6.6 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 6.27 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.53 | |||||
| 9-Day RSI | 63.94 | |||||
| 14-Day RSI | 61 | |||||
| 6-1 Month Momentum % | 15.12 | |||||
| 12-1 Month Momentum % | 14.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.88 | |||||
| Quick Ratio | 1.08 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 56.37 | |||||
| Days Sales Outstanding | 40.45 | |||||
| Days Payable | 43.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.5 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.97 | |||||
| Operating Margin % | -0.02 | |||||
| Net Margin % | -0.28 | |||||
| ROE % | -0.86 | |||||
| ROA % | -0.38 | |||||
| ROIC % | -0.02 | |||||
| ROC (Joel Greenblatt) % | 0.28 | |||||
| ROCE % | 0.07 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.62 | |||||
| PB Ratio | 1.94 | |||||
| Price-to-Free-Cash-Flow | 908.93 | |||||
| Price-to-Operating-Cash-Flow | 46.78 | |||||
| EV-to-EBIT | 1945.63 | |||||
| EV-to-EBITDA | 19.64 | |||||
| EV-to-Revenue | 0.84 | |||||
| EV-to-FCF | 1943.18 | |||||
| Earnings Yield (Greenblatt) % | 0.05 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CVET
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,649 | ||
| EPS (TTM) ($) | -0.1 | ||
| Beta | 1.52 | ||
| Volatility % | 64.21 | ||
| 14-Day RSI | 61 | ||
| 14-Day ATR ($) | 0.057979 | ||
| 20-Day SMA ($) | 20.866 | ||
| 12-1 Month Momentum % | 14.49 | ||
| 52-Week Range ($) | 13.39 - 21.2 | ||
| Shares Outstanding (Mil) | 140.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Covetrus Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Covetrus Inc Analysis
Share your researchHeadlines
See More
No news.